1. Trends in Management and Outcomes of Acute Nonvariceal Upper Gastrointestinal Bleeding: 1993–2003 
Laura E. Targownik, Alice Nabalamba 
Clinical Gastroenterology and Hepatology 
Volume 4, Issue 12, Pages e1 (December 2006)
DOI: /j.cgh
Copyright © 2006 AGA Institute Terms and Conditions

2. Figure 1
Trends in the incidence of ANVUGIB in Canada between 1993 and 2003.
Clinical Gastroenterology and Hepatology 2006 4, e1DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions

3. Figure 2
Trends in the incidence of ANVUGIB (strict definition) in Canada between 1993 and 2003, stratified by age. -+-, 18–39 y; -x-, 40–59 y; ▴, 60–69 y; , 70–79 y; ■, 80+ y.
Clinical Gastroenterology and Hepatology 2006 4, e1DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions

4. Figure 3
Proportion of ANVUGIB patients receiving upper-gastrointestinal surgery for control of bleeding. -+-, overall surgery; ■, category A surgery; •, category B surgery.
Clinical Gastroenterology and Hepatology 2006 4, e1DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions

5. Figure 4
Mortality rates for ANVUGIB patients in the hospital between 1993–1994 and 2002–2003, stratified by age. -x-, 18–59 y; ▴, 60–69 y; , 70–79 y; ■, 80+ y; - - • - -, overall.
Clinical Gastroenterology and Hepatology 2006 4, e1DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions

6. Figure 5
Trends in the LOHS: 1993–1994 to 2002–2003. •, 18–59 y; ▴, 60–69 y; , 70–79 y; ■, 80+ y; , overall.
Clinical Gastroenterology and Hepatology 2006 4, e1DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions

7. Figure 6
Proportion of ANVUGIB subjects with LOHS of less than 48 hours or more than 7 days: 1993–1994 to 2002–2003. •, LOHS ≤ 2 days; ▴, LOHS ≥ 5 days.
Clinical Gastroenterology and Hepatology 2006 4, e1DOI: ( /j.cgh )
Copyright © 2006 AGA Institute Terms and Conditions